Browsing Category

Top Industry News

7660 posts

Supplier News: SK pharmteco, Piramal & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring SK pharmteco, Eurofins CDMO Alphora, Piramal Pharma, and Cytovance Biologics.   Chemicals/Chemical API Manufacturing * SK pharmteco Opens Expansions for Small-Molecules and HPAPIs * Eurofins…

Global Briefs: Eli Lilly and Company & Sandoz 
By

By
A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Eli Lilly and Company & Sandoz. Highlights below.   For the latest news roundup on small and Emerging Pharma…

Biotech Briefs: Scholar Rock, Vaderis, Tolerance Bio & More 
By

By
The latest from small and Emerging Pharma companies featuring Scholar Rock, Vaderis Therapeutics, Tolerance Bio, NeoImmuneTech, Fulcrum Therapeutics, Slate Medicines, Infinimmune and Replimmune.  For news on the large and mid-sized…

BMS Investing $2.3 Bn in Multi-Modal Mfg Campus in Houston 
By

By
Bristol Myers Squibb (BMS) announced this week (August 10, 2026) the selection of Houston, Texas, as the site for a new $2.3-billion, 600,000-square-foot multi-modal manufacturing campus as part of the…

Novo Nordisk, Amazon in AI Pact for Drug Discovery; Create London Innovation Hub 
By

By
Novo Nordisk and Amazon Web Services (AWS) have formed a strategic partnership to accelerate drug discovery and modernize Novo Nordisk’s operations through agentic AI and cloud technologies. As part of…

Jazz Pharmaceuticals To Acquire Actio Biosciences in $1.3-Bn Deal 
By

By
To boost its rare-disease drug portfolio, Jazz Pharmaceuticals, a Dublin, Ireland-based bio/pharmaceutical company, has agreed to acquire Actio Biosciences, a San Diego, California-based clinical-stage bio/pharmaceutical company developing small molecules for…

Supplier News: CordenPharma, Cambrex, Thermo Fisher & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring  CordenPharma, Cambrex, Thermo Fisher, LTS Lohmann Therapie-Systeme, Polpharma API, and Pace.  Chemicals/Chemical API Manufacturing * CordenPharma Completes Acquisition of Peptide CDMO AmbioPharm* Cambrex…

Global Briefs: Lilly, Takeda, Moderna, Sobi, Zealand Pharma & More 
By

By
A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Eli Lilly and Company, Takeda, Moderna, Sobi, Zealand Pharma, and Zydus Life Sciences. Highlights below.  For the latest…

Biotech Briefs: Tarsus Pharma
By

By
The latest from small and Emerging Pharma companies featuring Tarsus Pharmaceuticals. For news on the large and mid-sized bio/pharmaceutical companies, see Global Briefs. *Tarsus Pharmaceuticals To Acquire Alkeus Pharma in…

Pfizer Announces Additional $2.5-Bn Restructuring Plan 
By

By
Pfizer has initiated an additional $2.5-billion restructuring plan, expected to realize savings from 2027 through 2029. The company made the announcement as part of its second-quarter/first-half 2026 results announced this week (August 4, 2026).   Approximately $1.0 billion of the additional cuts will come from the company’s ongoing overall cost realignment program…